Literature DB >> 24900214

Fluorinated Benzofuran Derivatives for PET Imaging of β-Amyloid Plaques in Alzheimer's Disease Brains.

Yan Cheng1, Masahiro Ono1, Hiroyuki Kimura1, Shinya Kagawa2, Ryuichi Nishii2, Hidekazu Kawashima1, Hideo Saji1.   

Abstract

A series of fluorinated benzofuran derivatives as potential tracers for positron emission tomography (PET) targeting β-amyloid plaques in the brains of patients with Alzheimer's disease (AD) were synthesized and evaluated. The derivatives were produced using an intramolecular Wittig reaction. In experiments in vitro, all displayed high affinity for Aβ(1-42) aggregates with K i values in the nanomolar range. Radiofluorinated 17, [(18)F]17, in particular labeled β-amyloid plaques in sections of Tg2576 mouse brain and displayed high uptake (5.66% ID/g) at 10 min postinjection, sufficient for PET imaging. In addition, in vivo β-amyloid plaque labeling can be clearly demonstrated with [(18)F]17 in Tg2576 mice. In conclusion, [(18)F]17 may be useful for detecting β-amyloid plaques in patients with AD.

Entities:  

Keywords:  Alzheimer's disease; benzofuran; fluorine-18; positron emission tomography (PET)

Year:  2010        PMID: 24900214      PMCID: PMC4007906          DOI: 10.1021/ml100082x

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  25 in total

1.  Fluoro-pegylated (FPEG) imaging agents targeting Abeta aggregates.

Authors:  Karin A Stephenson; Rajesh Chandra; Zhi-Ping Zhuang; Catherine Hou; Shunichi Oya; Mei-Ping Kung; Hank F Kung
Journal:  Bioconjug Chem       Date:  2007 Jan-Feb       Impact factor: 4.774

2.  2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.

Authors:  Yukitsuka Kudo; Nobuyuki Okamura; Shozo Furumoto; Manabu Tashiro; Katsutoshi Furukawa; Masahiro Maruyama; Masatoshi Itoh; Ren Iwata; Kazuhiko Yanai; Hiroyuki Arai
Journal:  J Nucl Med       Date:  2007-04       Impact factor: 10.057

3.  F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.

Authors:  Wei Zhang; Shunichi Oya; Mei-Ping Kung; Catherine Hou; Donna L Maier; Hank F Kung
Journal:  Nucl Med Biol       Date:  2005-11       Impact factor: 2.408

4.  Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.

Authors:  Kooresh Shoghi-Jadid; Gary W Small; Eric D Agdeppa; Vladimir Kepe; Linda M Ercoli; Prabha Siddarth; Stephen Read; Nagichettiar Satyamurthy; Andrej Petric; Sung-Cheng Huang; Jorge R Barrio
Journal:  Am J Geriatr Psychiatry       Date:  2002 Jan-Feb       Impact factor: 4.105

5.  Benzofuran derivatives as Abeta-aggregate-specific imaging agents for Alzheimer's disease.

Authors:  Masahiro Ono; Mei-Ping Kung; Catherine Hou; Hank F Kung
Journal:  Nucl Med Biol       Date:  2002-08       Impact factor: 2.408

6.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

7.  Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.

Authors:  Seok Rye Choi; Geoff Golding; Zhiping Zhuang; Wei Zhang; Nathaniel Lim; Franz Hefti; Tyler E Benedum; Michael R Kilbourn; Daniel Skovronsky; Hank F Kung
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

Review 8.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

Authors:  Chester A Mathis; Yanming Wang; Daniel P Holt; Guo-Feng Huang; Manik L Debnath; William E Klunk
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

10.  11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease.

Authors:  Masahiro Ono; Alan Wilson; Jose Nobrega; David Westaway; Paul Verhoeff; Zhi-Ping Zhuang; Mei-Ping Kung; Hank F Kung
Journal:  Nucl Med Biol       Date:  2003-08       Impact factor: 2.408

View more
  5 in total

1.  (18)F-labeled phenyldiazenyl benzothiazole for in vivo imaging of neurofibrillary tangles in Alzheimer's disease brains.

Authors:  Kenji Matsumura; Masahiro Ono; Hiroyuki Kimura; Masashi Ueda; Yuji Nakamoto; Kaori Togashi; Yoko Okamoto; Masafumi Ihara; Ryosuke Takahashi; Hideo Saji
Journal:  ACS Med Chem Lett       Date:  2011-12-01       Impact factor: 4.345

2.  Benzothiazolium Derivative-Capped Silica Nanocomposites for β-Amyloid Imaging In Vivo.

Authors:  Lijun Ma; Shu Yang; Yufan Ma; Yuzhi Chen; Zhenguo Wang; Tony D James; Xuefei Wang; Zhuo Wang
Journal:  Anal Chem       Date:  2021-09-08       Impact factor: 6.986

3.  BODIPY-based molecular probe for imaging of cerebral β-amyloid plaques.

Authors:  Masahiro Ono; Hiroyuki Watanabe; Hiroyuki Kimura; Hideo Saji
Journal:  ACS Chem Neurosci       Date:  2012-02-17       Impact factor: 4.418

4.  Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer's disease.

Authors:  Masahiro Ono; Yan Cheng; Hiroyuki Kimura; Hiroyuki Watanabe; Kenji Matsumura; Masashi Yoshimura; Shimpei Iikuni; Yoko Okamoto; Masafumi Ihara; Ryosuke Takahashi; Hideo Saji
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

5.  Amyloid-β probes: Review of structure-activity and brain-kinetics relationships.

Authors:  Todd J Eckroat; Abdelrahman S Mayhoub; Sylvie Garneau-Tsodikova
Journal:  Beilstein J Org Chem       Date:  2013-05-28       Impact factor: 2.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.